What Percentage of Patients With Newly Diagnosed Carcinoma of the Prostate are Candidates for Surveillance? An Analysis of the CaPSURE ™ Database-Reference-Cited by-同舟云学术

What Percentage of Patients With Newly Diagnosed Carcinoma of the Prostate are Candidates for Surveillance? An Analysis of the CaPSURE ™ Database

Published:2008-10 Issue:4 Volume:180 Page:1330-1335
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Barocas Daniel A.¹,Cowan Janet E.²,Smith Joseph A.¹,Carroll Peter R.²,

Affiliation:

1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

2. Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF/Mt. Zion Comprehensive Cancer Center, University of California San Francisco, San Francisco, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer;Epstein;JAMA,1994

3. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate;Carter;J Urol,1997

4. Active surveillance for prostate cancer: for whom?;Klotz;J Clin Oncol,2005

5. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results;Carter;J Urol,2002

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased α2,3‐sialyl N‐glycosylated prostate‐specific membrane antigen (PSMA) in post‐DRE urine is associated with high grade group prostate cancer;The Prostate;2024-05-12

2. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer;Urology Practice;2024-05

3. Fucosylated Proteins as Cancer Biomarkers;Glycosignals in Cancer;2023

4. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists;BMC Cancer;2021-05-31

5. Serum core‐type fucosylated prostate‐specific antigen index for the detection of high‐risk prostate cancer;International Journal of Cancer;2021-02-26